Comparison
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874 vs 3p25 3 Microdeletion Syndrome C5437630
Clinical comparison between 46 XX Disorder OF Sex Development Induced BY Exogenous Maternal Derived Androgen and 3p25 3 Microdeletion Syndrome for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
A condition caused when a pregnant person takes hormone medications containing androgens, affecting fetal development. The fetus has XX chromosomes. Stopping the offending agent is key, with specialist care for affected infants.
3p25 3 Microdeletion Syndrome C5437630
A genetic condition from missing chromosome material at 3p25, linked to developmental delays, distinctive features, and sometimes heart or other organ involvement.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
Variable
3p25 3 Microdeletion Syndrome C5437630
0-null
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
severe
3p25 3 Microdeletion Syndrome C5437630
moderate
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
Chronic
3p25 3 Microdeletion Syndrome C5437630
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
No
3p25 3 Microdeletion Syndrome C5437630
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
reproductive
3p25 3 Microdeletion Syndrome C5437630
congenital
Same/different system
Category
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
endocrine
3p25 3 Microdeletion Syndrome C5437630
genetic
Different category
Bottom line
46-xx-disorder-of-sex-development-induced-by-exogenous-maternal-derived-androgen-C5679874 and 3p25-3-microdeletion-syndrome-C5437630 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874 | 3p25 3 Microdeletion Syndrome C5437630 | Discriminating power |
|---|---|---|---|
| Genital development | Atypical genital development may occur in a 46,XX fetus after maternal androgen exposure. | Genital atypicality is not the defining feature; broader congenital findings may occur. | High |
| Development | Primary concern is sex development rather than a defined neurodevelopmental syndrome. | Developmental delay is a reported association, with variable severity. | Moderate |
| Dysmorphic or organ findings | Not characterized by a chromosomal deletion phenotype. | Distinctive features and sometimes heart or other organ involvement are described. | Moderate |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874 when
Documented maternal androgen-containing medication during pregnancy
The supplied etiology is exogenous maternal androgen exposure in an XX fetus.
High
Atypical genital findings with 46,XX karyotype
This pattern fits the described disorder of sex development better than a microdeletion.
Moderate
Need to stop an implicated androgen source
Source data identify stopping the offending agent and specialist infant care as key.
High
Choose 3p25 3 Microdeletion Syndrome C5437630 when
Suspected chromosomal copy-number abnormality
The condition is defined by missing material at 3p25.3.
High
Developmental delay with congenital anomalies
These associations are described for the microdeletion, not androgen exposure.
Moderate
No history of maternal androgen medication
Absence of exposure makes the exogenous androgen mechanism less likely, but does not prove the deletion.
Low
How key tests differ
| Test | 46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874 | 3p25 3 Microdeletion Syndrome C5437630 | Interpretation |
|---|---|---|---|
| Karyotype | 46,XX is part of the condition definition. | Routine karyotype may be normal because the change is a microdeletion. | A 46,XX result supports the left context but does not exclude other diagnoses. |
| Chromosomal microarray | No 3p25.3 deletion is expected from the supplied mechanism. | May detect missing material at 3p25.3. | A confirmed deletion supports the right diagnosis; clinician review is required. |
| Pregnancy medication review | Androgen-containing hormone medication is the implicated exposure. | No specific medication exposure is required. | Exposure history is supportive, not a laboratory diagnosis. |
Prognosis comparison
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
- Outcome
- Chronic effects may persist; prognosis is individualized and not quantified here.
- Factors
- Exposure timing, degree of atypical development, and access to specialist care.
3p25 3 Microdeletion Syndrome C5437630
- Outcome
- Chronic course with variable developmental and organ-related needs.
- Factors
- Deletion findings, developmental profile, and organ involvement.
Time frame: From prenatal or congenital onset into childhood and beyond; exact course is not established.
Etiology, associated anomalies, early evaluation, and supportive services.
Complications comparison
| Complication | Presentation |
|---|---|
| Genital and reproductive effects | May require specialist assessment of sex development and related anatomy. Not the primary described complication. Exact outcomes and interventions are not established here. |
| Neurodevelopment | Not defined as a developmental-delay syndrome in the source. Developmental delay is a reported feature. Severity and functional impact vary and need individual assessment. |
| Organ involvement | Source emphasizes fetal sex development rather than multiorgan malformation. Heart or other organs may sometimes be involved. Organ screening should follow specialist judgment, not a fixed protocol from these data. |
Patient education highlights
- HighDifferent causes
One condition is linked to pregnancy androgen exposure in an XX fetus; the other is a chromosomal microdeletion.
- HighSpecialist care
Endocrine, genetics, and pediatric specialists should interpret results and guide care.
- MediumAvoid unsupported numbers
Prevalence, exact laboratory cutoffs, mortality, and treatment doses are not established by this comparison.